Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M903Revenue $M24.1Net Margin (%)-80.0Z-Score13.2
Enterprise Value $M741EPS $-0.5Operating Margin %-80.7F-Score3
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-80.0Higher ROA y-yY
Price/Book4.310-y EBITDA Growth Rate %-1.7Quick Ratio8.9Cash flow > EarningsY
Price/Sales23.25-y EBITDA Growth Rate %-1.9Current Ratio8.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-14.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-17.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M68.4ROI % (ttm)-33.3Gross Margin Increase y-yN

Gurus Latest Trades with SGMO

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGMOJean-Marie Eveillard 2014-06-30 Add0.01%$11.71 - $17.95
($14.37)
$ 13.2-8%Add 34.1%536,380
SGMOJean-Marie Eveillard 2014-03-31 Reduce-0.02%$13.25 - $23.86
($19.12)
$ 13.2-31%Reduce -52.81%400,000
SGMOJean-Marie Eveillard 2013-09-30 Add0.01%$7.92 - $11.28
($9.95)
$ 13.233%Add 99.73%847,550
SGMOJean-Marie Eveillard 2013-06-30 Add$7.31 - $10.65
($8.72)
$ 13.251%Add 41.45%424,350
SGMOJean-Marie Eveillard 2013-03-31 Buy 0.01%$6.01 - $10.8
($8.89)
$ 13.248%New holding, 300000 sh.300,000
SGMOJean-Marie Eveillard 2010-03-31 Sold Out $4.76 - $6.63
($5.63)
$ 13.2134%Sold Out0
SGMOJean-Marie Eveillard 2009-12-31 Buy $5.04 - $8.09
($5.87)
$ 13.2125%New holding, 470 sh.470
SGMOJean-Marie Eveillard 2009-09-30 Sold Out -0.01%$4.26 - $9.03
($6.32)
$ 13.2109%Sold Out0
SGMOJean-Marie Eveillard 2009-06-30 Buy 0.01%$3.51 - $4.98
($4.2)
$ 13.2214%New holding, 260600 sh.260,600
SGMOJean-Marie Eveillard 2009-03-31 Sold Out -0.01%$2.99 - $5.05
($4.1)
$ 13.2222%Sold Out0
SGMOJean-Marie Eveillard 2008-12-31 Buy 0.01%$2.13 - $7.81
($4.6)
$ 13.2187%New holding, 288000 sh.288,000
SGMOJean-Marie Eveillard 2008-06-30 Sold Out $9.07 - $13.37
($11.3)
$ 13.217%Sold Out0
SGMOJean-Marie Eveillard 2007-12-31 Buy 0.01%$12.81 - $18.5
($15.1)
$ 13.2-13%New holding, 50000 sh.50,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGMO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SGMO Jean-Marie Eveillard 2014-09-30536,3800.780.01
SGMO - CALLJean-Marie Eveillard 2014-09-304,0000.010
Premium Most recent portfolio changes are included for Premium Members only!


SGMO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANPHIER EDWARD O IIPresident & CEO 2015-01-16Sell25,000$14.22-7.17view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-01-05Sell15,000$15.19-13.1view
LARSON JOHN WILLIAMDirector 2015-01-05Sell15,000$15.1-12.58view
RINGO WILLIAM RDirector 2015-01-05Sell2,200$15.2-13.16view
Gregory Philip DSVP, Research & CSO 2015-01-02Sell15,000$15.78-16.35view
LARSON JOHN WILLIAMDirector 2014-12-15Sell10,000$16.28-18.92view
LANPHIER EDWARD O IIPresident & CEO 2014-12-15Sell25,000$15.4-14.29view
Mento Steven JDirector 2014-12-11Sell6,354$15-12view
LARSON JOHN WILLIAMDirector 2014-12-09Sell10,000$1210view
ANDO DALE GVP, Therapeutic Dev. & CMO 2014-12-05Sell15,000$11.2117.75view

Press Releases about SGMO :

    Quarterly/Annual Reports about SGMO:

    News about SGMO:

    Articles On GuruFocus.com
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 03 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 06 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 03 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2009 
    Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results Feb 04 2009 

    More From Other Websites
    Sangamo BioSciences To Highlight 2015 Catalysts And Advancement Of ZFP Therapeutic Programs At The... Jan 12 2015
    Sangamo BioSciences To Highlight 2015 Catalysts And Advancement Of ZFP Therapeutic Programs At The... Jan 12 2015
    How to play the JPMorgan health conference Jan 09 2015
    Sangamo BioSciences Announces In-Licensing Of mRNA Delivery Technology And Expansion Of Therapeutic... Jan 08 2015
    Sangamo BioSciences Announces In-Licensing Of mRNA Delivery Technology And Expansion Of Therapeutic... Jan 08 2015
    Sangamo BioSciences Announces Presentation At The 33rd Annual J.P. Morgan Healthcare Conference Jan 05 2015
    Sangamo BioSciences Announces Presentation At The 33rd Annual J.P. Morgan Healthcare Conference Jan 05 2015
    2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses Dec 18 2014
    Is Sangamo The Next Biotech Stock To Break Out? Dec 17 2014
    Sangamo Biosciences (SGMO) Jumps: Stock Rises 7.2% Dec 12 2014
    Sangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad... Dec 08 2014
    Sangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad... Dec 08 2014
    Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo... Nov 19 2014
    Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo... Nov 19 2014
    Sangamo BioSciences Announces Presentation at the 26th Annual Piper Jaffray Healthcare Conference Nov 18 2014
    Sangamo BioSciences Announces Presentation at the 26th Annual Piper Jaffray Healthcare Conference Nov 18 2014
    Insider Trading Alert - CCOI, CRM And SGMO Traded By Insiders Nov 14 2014
    Sangamo BioSciences President and CEO Edward Lanphier to Serve as Chairman of the Alliance for... Nov 10 2014
    Sangamo BioSciences President and CEO Edward Lanphier to Serve as Chairman of the Alliance for... Nov 10 2014
    SANGAMO BIOSCIENCES INC Financials Nov 04 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK